Details for Patent: 6,142,145
Summary for Patent: 6,142,145
| Title: | Inhalation device |
| Abstract: | An inhaler for administering powder by inhalation, including an inhaler body having two ends and a peripheral wall therebetween; an inhalation unit disposed in the inhaler body, the inhalation unit comprising an inhalation channel, the inhalation channel having an air inlet and an outlet; a dosing unit disposed in the inhaler body for providing a dose of powder to the inhalation channel such that a stream of air containing powder may be drawn from the outlet of the inhalation channel on inhalation by a user; a divider having a first surface bounded by a periphery and which substantially closes one end of the inhaler body; a mouthpiece attached to the periphery of the divider, the mouthpiece having a substantially radially directed flange which provides a second surface and which, together with the first surface, defines an air chamber; a first inlet for the air chamber provided in the first surface within the periphery of the divider and in fluid communication with the outlet of the inhalation channel; a second inlet for the air chamber disposed in the first surface within the periphery of the divider and adjacent the first inlet, a stream of supplementary air in use being drawn through the second inlet on inhalation by the user; and a discrete opening in peripheral wall of the inhaler body which is in fluid communication with the second inlet of the air chamber. |
| Inventor(s): | Allan Dagsland, Karin Malmqvist-Granlund, Risto Virtanen |
| Assignee: | AstraZeneca AB |
| Application Number: | US09/068,379 |
|
Patent Claim Types: see list of patent claims | Delivery; |
Drugs Protected by US Patent 6,142,145
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,142,145
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 9700940 | Mar 14, 1997 |
| PCT Information | |||
| PCT Filed | March 13, 1998 | PCT Application Number: | PCT/SE98/00460 |
| PCT Publication Date: | September 24, 1998 | PCT Publication Number: | WO98/41259 |
International Family Members for US Patent 6,142,145
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 6430698 | ⤷ Start Trial | |||
| European Patent Office | 0975382 | ⤷ Start Trial | |||
| Sweden | 9700940 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
